About   Help   FAQ
Due to maintenance, access to MGI maybe intermittent on Thu, May 23 at 7:30 AM ET.
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Irf8
interferon regulatory factor 8
MGI:96395
48 phenotypes from 6 alleles in 8 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Cd19tm1(cre)Cgn/Cd19+
Irf8tm1.1Hm/Irf8tm1.1Hm
involves: 129P2/OlaHsd * C57BL/6
abnormal spleen marginal zone morphology J:168923
decreased follicular B cell number J:168923
normal immune system phenotype J:168923
increased B cell number J:168923
increased B-2 B cell number J:168923
increased follicular B cell number J:168923
increased marginal zone B cell number J:168923
increased transitional stage B cell number J:168923
Irf8M1Btlr/Irf8M1Btlr
C57BL/6J-Irf8M1Btlr
abnormal interferon secretion J:166600
decreased macrophage cell number J:166600
decreased monocyte cell number J:166600
increased neutrophil cell number J:166600
Irf8myls/Irf8+
involves: BXH2/TyJ * C57BL/6
increased B cell number J:168923
increased B-1b cell number J:168923
increased follicular B cell number J:168923
increased transitional stage B cell number J:168923
Irf8myls/Irf8myls
involves: BALB/cJ * BXH2/TyJ-Irf8myls
abnormal myelopoiesis J:97931
enlarged spleen J:97931
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
C57BL/6N-Irf8tm1b(KOMP)Wtsi/J
abnormal behavior J:211773
abnormal sleep behavior J:211773
decreased fasted circulating glucose level J:211773
increased circulating chloride level J:211773
increased circulating sodium level J:211773
increased prepulse inhibition J:211773
Irf8tm1Hor/Irf8+
either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)
abnormal definitive hematopoiesis J:36038
increased chronic myelocytic leukemia incidence J:36038
premature death J:36038
Irf8tm1Hor/Irf8tm1Hor
B6.129P2-Irf8tm1Hor
decreased follicular B cell number J:168923
increased B-1b cell number J:168923
increased marginal zone B cell number J:168923
Irf8tm1Hor/Irf8tm1Hor
either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)
abnormal cytotoxic T cell physiology J:36038
abnormal erythropoiesis J:36038
abnormal megakaryocyte morphology J:36038
abnormal plasma cell number J:36038
decreased B cell number J:36038
decreased interferon-gamma secretion J:36038
decreased lymphocyte cell number J:36038
decreased T cell number J:36038
enlarged liver J:36038
enlarged lymph nodes J:36038
enlarged spleen J:36038
increased B cell number J:36038
increased bone marrow cell number J:36038
increased chronic myelocytic leukemia incidence J:36038
increased granulocyte number J:36038
increased immunoglobulin level J:36038
increased leukocyte cell number J:36038
increased lymphocyte cell number J:36038
increased lymphoma incidence J:36038
increased macrophage cell number J:36038
increased mature B cell number J:36038
increased sensitivity to induced morbidity/mortality J:36038
increased spleen red pulp amount J:36038
increased susceptibility to viral infection J:36038
premature death J:36038
spleen hyperplasia J:36038
Irf8tm1Hor/Irf8tm1Hor
involves: 129P2/OlaHsd * C57BL/6
abnormal humoral immune response J:181366
Irf8tm2.1Hm/Irf8tm2.1Hm
involves: C57BL/6
no abnormal phenotype detected J:218664

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
05/14/2019
MGI 6.14
The Jackson Laboratory